This volume presents an up-to-date compendium of major scientific breakthroughs on human diseases, drug screenings, personalized medicine and regenerative approaches by using stem cells to model or treat the disorders
This book covers what would be the desired strategy for the years to come, by methodically dissecting limitations in our current methodology and understanding of stem cells technology
This book also summarizes state-of-the-art technology (genomics and epigenomics, crispr/cas9, epigenetic tools, bioinformatics approaches, etc) that will push further the applicability and validity of the stem cell application in biomedical research
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Raul Delgado-Morales holds a PhD in Neuroscience. He completed his doctoral studies at the Universitat Autònoma de Barcelona working in the field of epigenetics as it relates to depression. After that he received a Marie Curie Postdoctoral Fellowship, to continue his research as a postdoc at the Max Planck Institute of Psychiatry in Munich. There he focused on Alzheimer’s disease. After four years in Germany, he moved to Bellvitge Biomedical Research Institute (IDIBELL), in Barcelona, to lead research on neuroepigenomics. Currently he is the Scientific Deputy Director of IDIBELL.
This book looks at where stem cell technology is presently and how it is instrumental in advancing the field of disease modeling and cell transplantation. By focusing on major human disorders such as Alzheimer’s disease, cancer, and heart disorders, the book summarizes the major findings in the field of human stem cells and dissect the current limitations on our understanding of stem cells biology. The chapters focus on the genetics, genomics, epigenetics and physiology of stem cells models, together with technological advances on molecular biology such as CRISPR/Cas9 or epigenetic editing, that will be instrumental in the future of human disease modeling and treatment.
In base of the limitations of current disease models and in front of the unmet necessity of finding therapeutical interventions for human disorders, the availability of stem cell technology has opened new doors for several fields. The unlimited self-renewal capacity and more extensive differentiation potential of stem cells offers a theoretically inexhaustible and replenishable source of any cell subtype. Since Professor Shinya Yamanaka described it, 10 years ago in his seminal paper, that somatic cells could be reprogrammed to inducible stem cells (iPSC) just by expressing four transcription factors, the field of has exploded, especially its applications in biomedical research.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
Zustand: new. Questo è un articolo print on demand. Bestandsnummer des Verkäufers 7cc945d7439a97f6356250bc47e190b5
Anzahl: Mehr als 20 verfügbar
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book looks at where stem cell technology is presently and how it is instrumentalin advancing the field of disease modeling and cell transplantation. By focusing onmajor human disorders such as Alzheimer's disease, cancer, and heart disorders, thebook summarizes the major findings in the field of human stem cells and dissectthe current limitations on our understanding of stem cells biology. The chaptersfocus on the genetics, genomics, epigenetics and physiology of stem cells models,together with technological advances on molecular biology such as CRISPR/Cas9 orepigenetic editing, that will be instrumental in the future of human disease modelingand treatment.In base of the limitations of current disease models and in front of the unmet necessityof finding therapeutical interventions for human disorders, the availability of stemcell technology has opened new doors for several fields. The unlimited self-renewalcapacity and more extensive differentiation potential of stem cells offers a theoreticallyinexhaustible and replenishable source of any cell subtype. Since Professor ShinyaYamanaka described it, 10 years ago in his seminal paper, that somatic cells could bereprogrammed to inducible stem cells (iPSC) just by expressing four transcriptionfactors, the field of has exploded, especially its applications in biomedical research. 440 pp. Englisch. Bestandsnummer des Verkäufers 9783030080761
Anzahl: 2 verfügbar
Anbieter: moluna, Greven, Deutschland
Zustand: New. Bestandsnummer des Verkäufers 448671183
Anzahl: Mehr als 20 verfügbar
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Stem Cell Genetics for Biomedical Research | Past, Present, and Future | Raul Delgado-Morales | Taschenbuch | xi | Englisch | 2018 | Springer | EAN 9783030080761 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. Bestandsnummer des Verkäufers 117547133
Anzahl: 5 verfügbar
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. Softcover reprint of the original 1st ed. 2018 edition NO-PA16APR2015-KAP. Bestandsnummer des Verkäufers 26376478295
Anzahl: 4 verfügbar
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book looks at where stem cell technology is presently and how it is instrumental in advancing the field of disease modeling and cell transplantation. By focusing on major human disorders such as Alzheimer¿s disease, cancer, and heart disorders, the book summarizes the major findings in the field of human stem cells and dissect the current limitations on our understanding of stem cells biology. The chapters focus on the genetics, genomics, epigenetics and physiology of stem cells models, together with technological advances on molecular biology such as CRISPR/Cas9 or epigenetic editing, that will be instrumental in the future of human disease modeling and treatment.In base of the limitations of current disease models and in front of the unmet necessity of finding therapeutical interventions for human disorders, the availability of stem cell technology has opened new doors for several fields. The unlimited self-renewal capacity and more extensive differentiation potential of stem cells offers a theoretically inexhaustible and replenishable source of any cell subtype. Since Professor Shinya Yamanaka described it, 10 years ago in his seminal paper, that somatic cells could be reprogrammed to inducible stem cells (iPSC) just by expressing four transcription factors, the field of has exploded, especially its applications in biomedical research.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 440 pp. Englisch. Bestandsnummer des Verkäufers 9783030080761
Anzahl: 1 verfügbar
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book looks at where stem cell technology is presently and how it is instrumentalin advancing the field of disease modeling and cell transplantation. By focusing onmajor human disorders such as Alzheimer's disease, cancer, and heart disorders, thebook summarizes the major findings in the field of human stem cells and dissectthe current limitations on our understanding of stem cells biology. The chaptersfocus on the genetics, genomics, epigenetics and physiology of stem cells models,together with technological advances on molecular biology such as CRISPR/Cas9 orepigenetic editing, that will be instrumental in the future of human disease modelingand treatment.In base of the limitations of current disease models and in front of the unmet necessityof finding therapeutical interventions for human disorders, the availability of stemcell technology has opened new doors for several fields. The unlimited self-renewalcapacity and more extensive differentiation potential of stem cells offers a theoreticallyinexhaustible and replenishable source of any cell subtype. Since Professor ShinyaYamanaka described it, 10 years ago in his seminal paper, that somatic cells could bereprogrammed to inducible stem cells (iPSC) just by expressing four transcriptionfactors, the field of has exploded, especially its applications in biomedical research. Bestandsnummer des Verkäufers 9783030080761
Anzahl: 1 verfügbar
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. Print on Demand. Bestandsnummer des Verkäufers 369567112
Anzahl: 4 verfügbar
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New. PRINT ON DEMAND. Bestandsnummer des Verkäufers 18376478301
Anzahl: 4 verfügbar
Anbieter: Mispah books, Redhill, SURRE, Vereinigtes Königreich
Paperback. Zustand: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book. Bestandsnummer des Verkäufers ERICA80030300807656
Anzahl: 1 verfügbar